Journal of Parkinson’s Disease

Impact Factor
2022
5.520

Volume

12, 8 issues

Latest issue

12:7 online 14 October 2022

Next issue

12:8 scheduled for December 2022

Back volumes

From volume 1, 2011

ISSN print

1877-7171

ISSN online

1877-718X

Aims & Scope

The Journal of Parkinson’s Disease is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of Parkinson’s disease. The journal is international and multidisciplinary and aims to promote progress in the epidemiology, etiology, genetics, molecular correlates, pathogenesis, pharmacology, psychology, diagnosis and treatment of Parkinson’s disease. It will publish research reports, reviews, short communications, and letters-to-the-editor and offers very rapid publication and an affordable open access option.

Editorial Board

The full editorial board of the Journal of Parkinson's Disease can be found on its dedicated website here: Editorial Board.

Author Guidelines

SUBMISSION OF MANUSCRIPT

By submitting my article to this journal, I agree to the Author Copyright Agreement, the IOS Press Ethics Policy, and the IOS Press Privacy Policy.

Please click here to pay your publication fee and/or open access fee. Note: Corresponding authors from eligible institutions may be eligible to a waiver or discount on the open access fee; see here for more details.

See the full instructions to authors on the JPD website.

COPYRIGHT

Copyright of your article
Authors submitting a manuscript do so on the understanding that they have read and agreed to the terms of the IOS Press Author Copyright Agreement.

Article sharing
Authors of journal articles are permitted to self-archive and share their work through institutional repositories, personal websites, and preprint servers. Authors have the right to use excerpts of their article in other works written by the authors themselves, provided that the original work is properly cited. The consent for sharing an article, in whole or in part, depends on the version of the article that is shared, where it is shared, and the copyright license under which the article is published. Please refer to the IOS Press Article Sharing Policy for further information.

Quoting from other publications
Authors, when quoting from someone else's work or when considering reproducing figures or tables from a book or journal article, should make sure that they are not infringing a copyright. Although in general authors may quote from other published works, permission should be obtained from the holder of the copyright if there will be substantial extracts or reproduction of tables, plates, or other figures. If the copyright holder is not the author of the quoted or reproduced material, it is recommended that the permission of the author should also be sought. Material in unpublished letters and manuscripts is also protected and must not be published unless permission has been obtained. Submission of a paper will be interpreted as a statement that the author has obtained all the necessary permission. A suitable acknowledgement of any borrowed material must always be made.

Please visit the IOS Press Authors page for further information.

Abstracted/Indexed in

Biomedical Reference Collection
Cabell's Guide or Directory
Chemical Abstracts Service (CAS)
Embase
MEDLINE
OA@PubMedCentral
PsycINFO
PubMed
PubsHub
SciVerse Scopus
Web of Science: Journal Citation Reports/Science Edition
Web of Science: Science Citation Index Expanded (SciSearch®)

Open Access

By default, articles published in the Journal of Parkinson’s Disease are available only to institutions and individuals with access rights. However, the journal offers all authors the option to purchase open access publication for their article as part of the IOS Press Open Library. This means that the final published version will be freely available to anyone worldwide, indefinitely, under a Creative Commons license and without the need to purchase access to the article. This is also referred to as “gold” open access.

Gold open access pricing
Authors who choose gold open access publication will be subject to an article publication charge of € 1250 / US$ 1450 for publication under the CC BY-NC 4.0 license or € 1850 / US$ 2080 for publication under the CC BY 4.0 license. Pricing is exclusive of possible taxes. After an article is accepted for publication, the corresponding author will be informed regarding the open access option during the production stages, and will have the opportunity to purchase open access for their article. It could be that the open access fee of an article is waived completely due an institutional agreement IOS Press has with the corresponding authors' institution. Please check the institutional agreements page for details.

Green open access
Authors who do not make use of the gold open access option may still make their article freely available using self-archiving, also referred to as green open access. Authors may make their final accepted manuscript available for free download from their personal or institutional website or institutional archive. This model is free for the author.

PubMedCentral deposits
This journal deposits all open access articles in PubMedCentral (PMC) as part of the IOS Press Open Library. If an author chooses to publish their paper with open access then the publisher will deposit the article in PMC upon publication.

New Co-Editor-in-Chief Appointed: A new co-Editor-in-Chief (EIC) joined the journal in May 2022. A heartfelt welcome to Lorraine Kalia, and huge thanks to the outgoing EIC Patrik Brundin. Read the news announcements here.

Social Media & Sign Ups: The Journal of Parkinson's Disease (JPD) is on Facebook and Twitter, with social media editor Rui Araújo, PhD
(University of Porto, Portugal) at the helm. Be sure to follow us and be part of the conversation! You can sign up to the JPD newsletter to receive alerts of new issues and other journal news via this link tiny.cc/JPDsignup & read the latest newsletter here.

Partnership with WPC: Since April 2020, JPD has partnered with the World Parkinson Coalition (WPC), an organization which fills a unique niche in the global Parkinson's community. The partnership will see our respective teams working together to give a platform to the latest developments in PD research. View the WPC website here.

Clinical Trials Highlights: At the start of 2019, a new journal section co-edited by Kevin McFarthing and Tanya Simuni was launched to raise awareness of the clinical trial landscape in Parkinson’s, promoting discussion and progress in the conduct and outcome of studies; view here.

Parkinson's Webinar Series: JPD works in partnership with The Cure Parkinson’s Trust and Van Andell Institute to produce a series of Quarterly Parkinson's Webinars. Discover more here. The topic of our latest webinar was Deep Brain Stimulation. Watch the webinar recording here.

JPD Open Access Special Issues: Repairing the Parkinsonian Brain – Vol.11, Iss.s2; Digital Technology in PD Care & Research – Vol.11, Iss.s1; Clinical Care of Parkinson's – Vol.10, Iss.s1; Gut-Brain Axis in PD – Vol.9, Iss.s2 poses the question as to whether PD stars in the gut for all patients or a small subgroup; and PD 20 Years from Now – Vol.8, Iss.s1 addresses where Parkinson's research & treatment will be 20 years from now and you can read more in the mailing here.

Latest Articles

Discover the contents of the latest journal issue:

Autopallidotomy: From Colloquial Term to Scientific Theory
Rodolfo Savica, Stuart J. McCarter

A Guide for the Differential Diagnosis of Multiple System Atrophy in Clinical Practice
Susanne E.M. Ten Holter, Linda Azevedo Kauppila, Bart van de Warrenburg, Bastiaan R. Bloem

Management of Sleep Disturbances in Parkinson’s Disease
Friederike Sixel-Döring, Lukas Schütz, Wiebke Hermann

The Role of Microelectrode Recording in Deep Brain Stimulation Surgery for Parkinson’s Disease: A Systematic Review and Meta-Analysis
Martin Geerlings, R. Saman Vinke, Ashok K. Selvaraj, Dejan Georgiev, Bastiaan R. Bloem, Rianne A.J. Esselink, Ronald H.M.A. Bartels

Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-Up
Angelo Antonini, K. Ray Chaudhuri, Rajesh Pahwa, Per Odin, Nataliya Titova, Sandeep Thakkar, Sonya J. Snedecor, Saket Hegde, Ali Alobaidi, Juan Carlos Parra, Cindy Zadikoff, Lars Bergmann, David G. Standaert

Sustainable Development Goals

The content of this journal relates to SDG:

sdg symbolsdg symbolsdg symbolsdg symbol

Visit the SDG page for more information.

Supporting Diversity and Inclusion

This journal supports IOS Press' actions relating to the Sustainable Development Goals (SDGs) and commits to the Diversity and Inclusion Statement.

dark blue banner for JPD author geo data for SDGs

More information will be available in due course. Check the SDGs page for updates.  

JPD special issue banner

JPD OA special issue banner

JPD sign-up-for-news-banner

JPD OA special issue banner

 

CPT ad on the JPD page

 

JPD webinar banner

 

EPDA ad on JPD page

 

WPC banner on JPD page

JPD COVID-19 content banner

   

PD webinar 14 banner